CAP2 and liver cancer: Given that CAP2 was already identified as a marker for early-stage liver cancer patients with negative alpha fetoprotein (AFP), we decided to focus our research analysis on the potential of ITGA6 as a diagnostic marker for early-stage liver cancer [10,11].